Skip to main content
. 2018 Dec 18;320(23):2448–2460. doi: 10.1001/jama.2018.18472

Figure 3. Physical Functioning Assessed by the 100-Point 36-Item Short Form Physical Component Score Among Patients With Chronic Noncancer Pain Who Received Opioids vs Placebo in 51 High-Quality Randomized Clinical Trials.

Figure 3.

The blue line represents the minimally important difference of 5 points on the 100-point 36-item Short Form physical component score. The dashed vertical line represents the overall pooled measure of association.

aWithin-group change from baseline data.

bBetween-group differences in change from baseline data.

cWeights are from random-effects analyses.

dComparison was morphine plus gabapentin vs gabapentin alone.

eComparison was morphine plus nortriptyline vs nortriptyline alone.